Adaptimmune Therapeutics plc American Depositary Shares

ADAP XNAS • BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

15M

Short interest (Oct 15)

11.8%

Net Short (Oct 27 ): 0.5%

Borrow Fee

11.01%

Available Shares

Price Chart

Company Overview

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

CIK: 0001621227

Asset Type: ADRC

Market Data

Market Cap: $14,551,332

Employees: 506

Status: Active

Short Interest

Current Borrow Fee 11.01%

Range: 11.01% - 11.01%

Available Shares 0

Range: 0 - 0

Recent Changes

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime